Cargando…
Clinical Responses to Rituximab in a Case of Neuroblastoma with Refractory Opsoclonus Myoclonus Ataxia Syndrome
Opsoclonus myoclonus ataxia syndrome (OMS) is a rare neurologic syndrome. In a high proportion of children, it is associated with neuroblastoma. The etiology of this condition is thought to be immune mediated. In children, immunotherapy with conventional treatments such as corticosteroids, intraveno...
Autores principales: | Alavi, Samin, Kord Valeshabad, Ali, Moradveisi, Borhan, Aminasnafi, Ali, Arzanian, Mohammad Taghi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502780/ https://www.ncbi.nlm.nih.gov/pubmed/23198199 http://dx.doi.org/10.1155/2012/164082 |
Ejemplares similares
-
Ataxia as Forme Fruste of Opsoclonus Myoclonus Ataxia Syndrome
por: Dhawan, Sumeet R., et al.
Publicado: (2020) -
Opsoclonus-myoclonus-ataxia syndrome in an AIDS patient
por: Vale, Thiago Cardoso, et al.
Publicado: (2013) -
Opsoclonus–myoclonus–ataxia syndrome in an HIV-infected child
por: Pereira, Noella Maria Delia, et al.
Publicado: (2016) -
Primary pancreatic neuroblastoma presenting with opsoclonus–myoclonus syndrome
por: Galgano, Samuel, et al.
Publicado: (2015) -
Opsoclonus myoclonus ataxia syndrome following COVID-19 infection
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2022)